We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+7.29%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$78.8B
AUM Growth
+$7.07B
Cap. Flow
+$2.22B
Cap. Flow %
2.81%
Top 10 Hldgs %
22%
Holding
3,838
New
237
Increased
1,800
Reduced
1,491
Closed
179

Sector Composition

Rank Sector Weight
1 Technology 11.07%
2 Financials 9.56%
3 Healthcare 8.56%
4 Industrials 6.35%
5 Communication Services 5.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MED icon
2376
Medifast
MED
$128M
$820K ﹤0.01%
7,479
+2,345
+46% +$227K
EDIV icon
2377
State Street SPDR S&P Emerging Markets Dividend ETF
EDIV
$1.22B
$819K ﹤0.01%
25,500
+373
+1% +$11.5K
WDFC icon
2378
WD-40
WDFC
$3.09B
$819K ﹤0.01%
4,217
-73
-2% -$13.8K
BCSF icon
2379
Bain Capital Specialty
BCSF
$821M
$818K ﹤0.01%
42,167
+13,594
+48% +$256K
RUN icon
2380
Sunrun
RUN
$2.37B
$817K ﹤0.01%
59,173
-13,188
-18% -$197K
DCF
2381
DELISTED
BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc.
DCF
$817K ﹤0.01%
88,395
+11,412
+15% +$104K
ACRE
2382
Ares Commercial Real Estate
ACRE
$264M
$815K ﹤0.01%
51,457
+19,407
+61% +$301K
MAV
2383
DELISTED
Pioneer Municipal High Income Advantage Fund
MAV
$815K ﹤0.01%
75,410
+827
+1% +$8.94K
MRK icon
2384
CALL
Merck
MRK
$334B
$814K ﹤0.01%
194,090
-1,886
-1% -$155K
FOLD
2385
DELISTED
Amicus Therapeutics
FOLD
$813K ﹤0.01%
83,469
+10,522
+14% +$96.3K
SHAK icon
2386
Shake Shack
SHAK
$2.98B
$813K ﹤0.01%
13,654
+8,178
+149% +$588K
LEVI icon
2387
Levi Strauss
LEVI
$8.63B
$812K ﹤0.01%
42,074
-4,000
-9% -$71.3K
QDEL icon
2388
QuidelOrtho
QDEL
$1.03B
$812K ﹤0.01%
10,816
-1,314
-11% -$84.9K
CGC
2389
Canopy Growth
CGC
$426M
$811K ﹤0.01%
3,860
+634
+20% +$126K
NCZ
2390
Virtus Convertible & Income Fund II
NCZ
$306M
$808K ﹤0.01%
39,455
+366
+0.9% +$7.33K
DWAQ
2391
DELISTED
Invesco DWA NASDAQ Momentum ETF
DWAQ
$806K ﹤0.01%
6,297
-375
-6% -$43K
CPE
2392
DELISTED
Callon Petroleum Company
CPE
$805K ﹤0.01%
+16,674
New +$690K
CHGG icon
2393
Chegg
CHGG
$89.3M
$804K ﹤0.01%
21,195
-12,775
-38% -$447K
NPV icon
2394
Nuveen Virginia Quality Municipal Income Fund
NPV
$216M
$801K ﹤0.01%
54,866
+44
+0.1% +$624
PSCC icon
2395
Invesco S&P SmallCap Consumer Staples ETF
PSCC
$42.1M
$801K ﹤0.01%
30,141
-2,241
-7% -$55.8K
FDLO icon
2396
Fidelity Low Volatility Factor ETF
FDLO
$1.46B
$800K ﹤0.01%
+20,674
New +$775K
PTEN icon
2397
Patterson-UTI
PTEN
$4.16B
$796K ﹤0.01%
75,806
-53,035
-41% -$480K
FFIN icon
2398
First Financial Bankshares
FFIN
$5.04B
$795K ﹤0.01%
22,643
+1,434
+7% +$49.4K
TSEM icon
2399
Tower Semiconductor
TSEM
$28.6B
$794K ﹤0.01%
33,214
+8,250
+33% +$185K
AXSM icon
2400
Axsome Therapeutics
AXSM
$11.2B
$793K ﹤0.01%
7,675
-15,696
-67% -$634K

Similar funds

Raymond James & Associates's Q4 2019 Portfolio in Review

As of Q4 2019, Raymond James & Associates held 3,838 positions worth $78.8B, up 9.9% from $71.7B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Raymond James & Associates's Q4 2019 filing shows 237 new, 1,800 increased, 1,491 reduced and 179 closed positions. Its largest new stake was Direxion Daily S&P 500 Bear 1X ETF: 343,036 shares worth $8.38M. The largest sale was iShares Core MSCI EAFE ETF, an estimated $325M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q4 2019 buy was Direxion Daily S&P 500 Bear 1X ETF: 343,036 shares worth $8.38M.
  • Raymond James & Associates added most to Vanguard High Dividend Yield ETF in Q4 2019, an estimated $672M increase.
  • Raymond James & Associates's biggest Q4 2019 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $325M.
  • Raymond James & Associates fully exited SunTrust Banks, Inc. in Q4 2019, selling an estimated $45.9M.
  • Raymond James & Associates's ten largest holdings make up 22% of its $78.8B portfolio in Q4 2019.
  • Raymond James & Associates opened 237 new positions and closed 179 in Q4 2019.
  • Raymond James & Associates's portfolio value rose 9.9% quarter-over-quarter to $78.8B.

Based on Raymond James & Associates's 13F filing for Q4 2019, filed 12 Feb 2020.